Table 1

Baseline characteristics (all-subjects-treated population [n = 82])

Sugammadex (n = 46)

Neostigmine (n = 36)


Gender

Female, n (%)

29 (63)

15 (42)

Male, n (%)

17 (37)

21 (58)

Mean (SD) age, years

50 (14)

57 (12)

Mean (SD) weight, kg

86 (19)

86 (18)

Mean (SD) height, cm

170 (11)

173 (10)

Race, n (%)

Asian

1 (2)

3 (8)

Black (of African heritage)

6 (13)

1 (3)

Caucasian

38 (83)

32 (89)

Other

1 (2)

0

ASA class, n (%)

1

6 (13)

1 (3)

2

34 (74)

22 (61)

3

6 (13)

13 (36)

4

0

0


ASA, American Society of Anesthesiologists.

Lemmens et al. BMC Anesthesiology 2010 10:15   doi:10.1186/1471-2253-10-15

Open Data